(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Keith Westby, Senior Vice President & COO, on April 18, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $166,300. Following the Form 4 filing with the...
IVERIC bio (ISEE) shares were up more than 6.0% in Tuesday afternoon trading after Jefferies started coverage on the stock with a buy rating and a $27...
IVERIC bio (ISEE) has an average rating of buy and price targets ranging from $21 to $27, according to analysts polled by Capital IQ. (MT Newswires covers...
Keith Westby, Senior Vice President & COO, on March 16, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $150,190. Following the Form 4 filing with the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
IVERIC Bio (ISEE) reported Thursday a Q4 diluted net loss of $0.29 per share, compared with a loss of $0.27 a year earlier. Analysts polled by Capital IQ...
Keith Westby, Senior Vice President & COO, on February 15, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $151,634. Following the Form 4 filing with the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...